Artificial intelligence software to help detect and characterise colorectal polypsStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: TBC
Catumaxomab for intraperitoneal treatment of malignant ascites in epithelial cellular adhesion molecule-positive carcinomas when further systemic anticancer treatment is unsuitable [ID6580]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 30 September 2026
COLOFIT algorithm to guide colorectal cancer pathway referral in primary care: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: TBC
Colon cancer (adjuvant) - irinotecan [ID379]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Lutetium oxodotreotide with octreotide for newly diagnosed unresectable or metastatic gastroenteropancreatic neuroendocrine tumours [ID6315]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Repotrectinib for treating NTRK fusion-positive advanced solid tumours in people 12 years and over [TSID12147]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Retifanlimab with platinum-based chemotherapy for treating inoperable, locally recurrent or metastatic squamous cell anal canal cancer untreated with systemic chemotherapy ID6482 [ID6482]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Suspected Cancer: recognition and referral (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 25 March 2026
Tucatinib with trastuzumab for previously treated HER2-positive colorectal cancer [ID6227]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC